ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs32.73 M30.68 M29.13 M29.22 M28.02 M34.69 M121.06 MRecherche et développement———————Résultat d'exploitation10.9 M126.64 M24.07 M-171.07 M-1.65 B473.44 M-1.32 BTotal des produits hors exploitation-67.99 M-49.99 M-30.62 M28.16 M-3.89 M-4.58 M-10.93 MCharges d'intérêts, nettes des intérêts capitalisés55.66 M50.88 M55.3 M54.85 M65.67 M64.58 M240.41 MRésultat hors exploitation, hors charges d'intérêts-123.65 M-100.87 M-85.92 M-26.69 M-69.56 M-69.17 M-251.34 MRevenus/dépenses exceptionnels———————Résultat avant impôts246.18 M352.76 M248.16 M58.82 M-1.31 B325.25 M-680.93 MPart des actionnaires dans le résultat6.63 M-507 K-9.02 M201 K-304 K-147 K-9.27 MImpôts———————Intérêts ne donnant pas le contrôle / intérêts minoritaires46.15 M47.6 M44.81 M34.91 M85.52 M36.72 M201.97 MAutres produits/charges après impôts———————Résultat net avant activités abandonnées-62.24 M-8.94 M-107 M-232.75 M-1.08 B361.65 M-1.06 BActivités abandonnées———————Résultat net-62.24 M-8.94 M-107 M-232.75 M-1.08 B361.65 M-1.06 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires-64.92 M-11.6 M-109.61 M-234.94 M-1.08 B358.87 M-1.07 BBénéfice par action de base (BPA de base)-0.38-0.07-0.64-1.38-6.352.1-6.27Bénéfice par action dilué (BPA dilué)-0.38-0.07-0.64-1.38-6.352.1-6.27Nombre moyen d'actions de base en circulation172.07 M170.52 M170.13 M170.18 M170.31 M170.6 M—Nombre d'actions en circulation après dilution172.07 M170.52 M170.13 M170.18 M170.31 M170.87 M—EBITDA-51.59 M81.04 M-17.6 M-230.74 M-1.61 B41.42 M-1.81 BEBIT-56.55 M76 M-22.55 M-235.57 M-1.61 B36.67 M-1.83 BCoût des ventes240.43 M226.4 M224.43 M239.23 M232.54 M224.14 M920.35 MAutres coûts des ventes240.43 M226.4 M224.43 M239.23 M232.54 M224.14 M920.35 MAmortissements (flux de trésorerie)4.95 M5.04 M4.95 M4.83 M4.81 M4.75 M19.34 M
Alexandria Real Estate Equities, Inc. Common Stock
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area.
The company is dependent on the life sciences industry and funding for research by the United States Government.
The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms.
The company is named after Alexandria, Egypt because of that city's connection to science.